Furthermore, FWBGI modulates mitochondrial regulation by increasing GLP-1 receptor (GLP-1R) expression and UCP2/3 activity in the liver and brain, suggesting a novel regulatory axis involving the brain, liver, and intestines for managing type 2 diabetes. Here, GLP1R is linked to type 2 diabetes mellitus.